Skip to content
★ Sign in to follow
AL

Alan Lotvin

Executive
Chief Executive Officer
CVS HEALTH CorpMagellan Health Inc
Total declarations
47
Companies
2
▲ Purchases (1 ops.)
€292k
▼ Sales (14 ops.)
€18.8M

Latest filing published 05 Aug 2022 for CVS HEALTH Corp, €6.8M.

Filing timeline

BuySale
Alan Lotvin

Insider track record

Disclosed buys
1
Disclosed sells
14
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 13 May 2020 · 2370 days ago · €292k
    +35.3%
    Entry US$62.31 · Close at T+365 US$84.33

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Alan Lotvin: trading record in brief

This profile gathers the share dealings of Alan Lotvin across 2 companies, led by CVS HEALTH Corp and Magellan Health Inc. Between 4 March 2010 and 4 August 2022, the trades on record add up to 47 filings.

Market trades split into 1 purchase (€292k) and 14 sales (€18.8M). The net balance comes to €18.6M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 21 share grants and 11 option exercises. In 2022 alone, the filings show no purchases and 4 sales.

The latest filing, published on 5 August 2022, reports an open-market sale of €6.8M in CVS HEALTH Corp. The most recent open-market purchase was published on 13 May 2020, 2,370 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Alan Lotvin

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations45 total
  • ▼
    EVP&President-PharmacyServicesExecutivesCVS HEALTH Corp
    7M USD36SEC
    70,398 shares@ US$98.0019.6% of flowCommon StockSEC:0001127602-22-020596:1
  • ◇
    EVP&President-PharmacyServicesExecutivesCVS HEALTH Corp
    3M USD23SEC
    50,501 shares@ US$54.197.8% of flowCommon StockSEC:0001127602-22-020596:2
  • ▼
    EVP&President-PharmacyServicesExecutivesCVS HEALTH Corp
    5M USD35SEC
    50,501 shares@ US$98.0014.1% of flowCommon StockSEC:0001127602-22-020596:3
  • ◇
    EVP&President-PharmacyServicesExecutivesCVS HEALTH Corp
    1M USD22SEC
    22,541 shares@ US$62.214.0% of flowCommon StockSEC:0001127602-22-020596:4
  • ▼
    EVP&President-PharmacyServicesExecutivesCVS HEALTH Corp
    2M USD35SEC
    22,541 shares@ US$104.006.6% of flowCommon StockSEC:0001127602-22-020596:5
  • ◇
    EVP&President-PharmacyServicesExecutivesCVS HEALTH Corp
    4M USD26SEC
    70,398 shares@ US$58.3441.8% of flowCommon StockSEC:0001127602-22-020596:0
  • ◆
    EVP&President-PharmacyServicesExecutivesCVS HEALTH Corp
    4M USD26SEC
    38,129 shares@ US$101.0936.0% of flowCommon StockSEC:0001127602-22-011636:0
  • ◆
    EVP&President-PharmacyServicesExecutivesCVS HEALTH Corp
    0SEC
    85,971 shares0Common StockSEC:0001127602-22-006291:0
  • ▼
    EVP&President-PharmacyServicesExecutivesCVS HEALTH Corp
    2M USD38SEC
    21,386 shares@ US$106.505.9% of flowCommon StockSEC:0001127602-22-002958:1
  • ◇
    EVP&President-PharmacyServicesExecutivesCVS HEALTH Corp
    2M USD24SEC
    21,386 shares@ US$102.2620.1% of flowCommon StockSEC:0001127602-22-002958:0
  • ◆
    EVP&President-PharmacyServicesExecutivesCVS HEALTH Corp
    17,756 USD22SEC
    200 shares@ US$88.780.2% of flowCommon Stock (restricted)SEC:0001127602-21-031962:0
  • ▼
    EVP&President-PharmacyServicesExecutivesCVS HEALTH Corp
    232,686 USD22SEC
    2,781 shares@ US$83.672.0% of flowCommon StockSEC:0001127602-21-020816:0
  • ◆
    EVP&President-PharmacyServicesExecutivesCVS HEALTH Corp
    126,682 USD24SEC
    1,705 shares@ US$74.300.7% of flowCommon StockSEC:0001127602-21-013214:0
  • ◆
    EVP&President-PharmacyServicesExecutivesCVS HEALTH Corp
    0SEC
    95,669 shares0Common StockSEC:0001127602-21-012762:0
  • ◆
    EVP&President-PharmacyServicesExecutivesCVS HEALTH Corp
    0SEC
    42,431 shares0Common StockSEC:0001127602-21-012762:1
  • ◇
    EVP and President-CVS CaremarkExecutivesCVS HEALTH Corp
    547,319 USD24SEC
    10,100 shares@ US$54.193.1% of flowCommon StockSEC:0001127602-21-001522:0
  • ◇
    EVP and President-CVS CaremarkExecutivesCVS HEALTH Corp
    1M USD25SEC
    15,736 shares@ US$74.296.5% of flowCommon StockSEC:0001127602-21-001522:1
  • ▼
    EVP and President-CVS CaremarkExecutivesCVS HEALTH Corp
    2M USD37SEC
    25,836 shares@ US$75.0010.8% of flowCommon StockSEC:0001127602-21-001522:2
  • ▼
    EVP and President-CVS CaremarkExecutivesCVS HEALTH Corp
    499,660 USD36SEC
    7,138 shares@ US$70.003.8% of flowCommon StockSEC:0001127602-20-029248:0
  • ▲
    EVP and President-CVS CaremarkExecutivesCVS HEALTH Corp
    315,700 USD22SEC
    5,000 shares@ US$63.142.6% of flowCommon StockSEC:0001127602-20-016337:0
    Canonical exit: 9 Aug 2020 (T+90)
  • ◆
    EVP, TransformationExecutivesCVS HEALTH Corp
    86,402 USD11SEC
    1,481 shares@ US$58.340.7% of flowCommon StockSEC:0001127602-20-013234:0
  • ◆
    EVP, TransformationExecutivesCVS HEALTH Corp
    9,469 USD11SEC
    160 shares@ US$59.180.1% of flowCommon StockSEC:0001127602-20-009164:0
  • ◆
    EVP, TransformationExecutivesCVS HEALTH Corp
    699,981 USD12SEC
    11,828 shares@ US$59.185.7% of flowStock UnitSEC:0001127602-20-009164:1
  • ◆
    EVP, TransformationExecutivesCVS HEALTH Corp
    46,766 USD11SEC
    863 shares@ US$54.190.4% of flowCommon StockSEC:0001127602-19-014675:0
  • ◆
    EVP, TransformationExecutivesCVS HEALTH Corp
    16,886 USD11SEC
    292 shares@ US$57.830.1% of flowCommon StockSEC:0001127602-19-009279:0

25 of 45 declarations